Cardiac Troponin Levels in Heart Failure

Cardiology in Review

Volumn 12, Issue 1, 2004, Pages 21-25

  Potluri, Srinivasa ^a   Ventura, Hector O ^a   Mulumudi, Mahesh ^a   Mehra, Mandeep R ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Cardiomyocite injury; Cardiovascular events; Heart failure; Troponin levels; Ventricular remodeling

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; TROPONIN I; TROPONIN T;

BIOLOGICAL MONITORING; CELL DAMAGE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HOSPITALIZATION; HUMAN; MUSCLE ATROPHY; OBSERVER VARIATION; PROGNOSIS; REVIEW; SYMPTOM;

BIOLOGICAL MARKERS; HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; TROPONIN; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0347510814     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.crd.0000089981.53961.cf     Document Type: Review

References (21)

1. Cohn JN. Structural basis for heart failure: ventricular remodeling and its pharmacological inhibition. Circulation. 1995;91:2504-2507.
2. Schaper J, Froede R, Hein ST, et al. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation. 1991;83:504-514.
3. Wu AH, Apple FS, Gibler WB, et al. National Academy of Clinical Biochemistry standards of laboratory practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem. 1999;45:1104-1121.
4. Ricchiuti V, Voss EM, Ney A, et al. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem. 1998;44:1919-1924.
5. Haller C, Zehelein J, Remppis A, et al. Cardiac troponin T in patients with end-stage renal disease: absence of expression in truncal skeletal muscle. Clin Chem. 1998;44:930-938.
6. Wong SS. Strategic utilization of cardiac markers for the diagnosis of acute myocardial infarction. Ann Clin Lab Sci. 1996;26:301-312.
7. Remppis A, Scheffold T, Greten J, et al. Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. J Mol Cell Cardiol. 1995;27:793-803.
8. Missov E, Calzolari C. Elevated cardiac troponin I in some patients with severe congestive heart failure [Abstract]. J Mol Cell Cardiol. 1995;27:A-405.
9. Missov E, Calzolari C, Pau B. High circulating levels of cardiac troponin I in human congestive heart failure [Abstract]. J Am Coll Cardiol. 1996;27(suppl A):338A.
10. Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation. 1997;96:2953-2958.
11. Jaffe AS. Pandora's box is torn asunder. Am Heart J. 1999;139:9-12.
12. La Vecchia L, Mezzena G, Ometto R, et al. Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin. Am J Cardiol. 1997;80:88-89.
13. La Vecchia L, Mezzena G, Zanolia L, et al. Cardiac troponin I as a diagnostic and prognostic marker in severe heart failure. J Heart Lung Transplant. 2000;19:644-652.
14. Logeart D, Beyne P, Cusson C, et al. Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain. Am Heart J. 2001;141:247-253.
15. Setsuta K, Ohtsuka T, Ogawa T, et al. Prognostic value of second generation cardiac troponin T in patients with chronic heart failure [Abstract]. J Am Coll Cardiol. 1998;31(suppl A):249A.
16. Missov E, Mair J. A novel biochemical approach to congestive heart failure: cardiac troponin T. Am Heart J. 1999;138:95-99.
17. Sato Y, Yamada T, Taniguchi R, et al. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation. 2001;103:369-374.
18. Sato Y, Taniguchi R, Makiyama T, et al. Serum cardiac troponin T and plasma brain natriuretic peptide in patients with cardiac decompensation. Heart. 2002;88:647-648.
19. Ishii J, Nomura M, Nakmura Y, et al. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol. 2002;89:691-695.
20. Cheng V, Kazanagra R, Garcia A, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol. 2001;37:386-391.
21. Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 2002;105:2392-2397.